Home Cart Sign in  
Chemical Structure| 126712-07-0 Chemical Structure| 126712-07-0

Structure of 126712-07-0

Chemical Structure| 126712-07-0

2-Bromo-6-methoxybenzaldehyde

CAS No.: 126712-07-0

4.5 *For Research Use Only !

Cat. No.: A168889 Purity: 95%

Change View

Size Price

US Stock

Global Stock

In Stock
100mg łË˶ÊÊ Inquiry Inquiry
250mg ł§ÿ¶ÊÊ Inquiry Inquiry
1g łÍ˶ÊÊ Inquiry Inquiry
5g łîó¶ÊÊ Inquiry Inquiry
25g ł§ËʶÊÊ Inquiry Inquiry

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • 100mg

    łË˶ÊÊ

  • 250mg

    ł§ÿ¶ÊÊ

  • 1g

    łÍ˶ÊÊ

  • 5g

    łîó¶ÊÊ

  • 25g

    ł§ËʶÊÊ

In Stock

- +

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of [ 126712-07-0 ]

CAS No. :126712-07-0
Formula : C8H7BrO2
M.W : 215.04
SMILES Code : O=CC1=C(OC)C=CC=C1Br
MDL No. :MFCD08059232
Boiling Point : No data available
InChI Key :RQLOLSOZFHENIV-UHFFFAOYSA-N
Pubchem ID :554845

Safety of [ 126712-07-0 ]

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Computational Chemistry of [ 126712-07-0 ] Show Less

Physicochemical Properties

Num. heavy atoms 11
Num. arom. heavy atoms 6
Fraction Csp3 0.12
Num. rotatable bonds 2
Num. H-bond acceptors 2.0
Num. H-bond donors 0.0
Molar Refractivity 46.02
TPSA ?

Topological Polar Surface Area: Calculated from
Ertl P. et al. 2000 J. Med. Chem.

26.3 Ų

Lipophilicity

Log Po/w (iLOGP)?

iLOGP: in-house physics-based method implemented from
Daina A et al. 2014 J. Chem. Inf. Model.

1.78
Log Po/w (XLOGP3)?

XLOGP3: Atomistic and knowledge-based method calculated by
XLOGP program, version 3.2.2, courtesy of CCBG, Shanghai Institute of Organic Chemistry

2.05
Log Po/w (WLOGP)?

WLOGP: Atomistic method implemented from
Wildman SA and Crippen GM. 1999 J. Chem. Inf. Model.

2.27
Log Po/w (MLOGP)?

MLOGP: Topological method implemented from
Moriguchi I. et al. 1992 Chem. Pharm. Bull.
Moriguchi I. et al. 1994 Chem. Pharm. Bull.
Lipinski PA. et al. 2001 Adv. Drug. Deliv. Rev.

1.86
Log Po/w (SILICOS-IT)?

SILICOS-IT: Hybrid fragmental/topological method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

2.65
Consensus Log Po/w?

Consensus Log Po/w: Average of all five predictions

2.12

Water Solubility

Log S (ESOL):?

ESOL: Topological method implemented from
Delaney JS. 2004 J. Chem. Inf. Model.

-2.74
Solubility 0.395 mg/ml ; 0.00183 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble
Log S (Ali)?

Ali: Topological method implemented from
Ali J. et al. 2012 J. Chem. Inf. Model.

-2.23
Solubility 1.26 mg/ml ; 0.00588 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble
Log S (SILICOS-IT)?

SILICOS-IT: Fragmental method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

-3.33
Solubility 0.0999 mg/ml ; 0.000465 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble

Pharmacokinetics

GI absorption?

Gatrointestinal absorption: according to the white of the BOILED-Egg

High
BBB permeant?

BBB permeation: according to the yolk of the BOILED-Egg

Yes
P-gp substrate?

P-glycoprotein substrate: SVM model built on 1033 molecules (training set)
and tested on 415 molecules (test set)
10-fold CV: ACC=0.72 / AUC=0.77
External: ACC=0.88 / AUC=0.94

No
CYP1A2 inhibitor?

Cytochrome P450 1A2 inhibitor: SVM model built on 9145 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.83 / AUC=0.90
External: ACC=0.84 / AUC=0.91

Yes
CYP2C19 inhibitor?

Cytochrome P450 2C19 inhibitor: SVM model built on 9272 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.80 / AUC=0.86
External: ACC=0.80 / AUC=0.87

No
CYP2C9 inhibitor?

Cytochrome P450 2C9 inhibitor: SVM model built on 5940 molecules (training set)
and tested on 2075 molecules (test set)
10-fold CV: ACC=0.78 / AUC=0.85
External: ACC=0.71 / AUC=0.81

No
CYP2D6 inhibitor?

Cytochrome P450 2D6 inhibitor: SVM model built on 3664 molecules (training set)
and tested on 1068 molecules (test set)
10-fold CV: ACC=0.79 / AUC=0.85
External: ACC=0.81 / AUC=0.87

No
CYP3A4 inhibitor?

Cytochrome P450 3A4 inhibitor: SVM model built on 7518 molecules (training set)
and tested on 2579 molecules (test set)
10-fold CV: ACC=0.77 / AUC=0.85
External: ACC=0.78 / AUC=0.86

No
Log Kp (skin permeation)?

Skin permeation: QSPR model implemented from
Potts RO and Guy RH. 1992 Pharm. Res.

-6.16 cm/s

Druglikeness

Lipinski?

Lipinski (Pfizer) filter: implemented from
Lipinski CA. et al. 2001 Adv. Drug Deliv. Rev.
MW ≤ 500
MLOGP ≤ 4.15
N or O ≤ 10
NH or OH ≤ 5

0.0
Ghose?

Ghose filter: implemented from
Ghose AK. et al. 1999 J. Comb. Chem.
160 ≤ MW ≤ 480
-0.4 ≤ WLOGP ≤ 5.6
40 ≤ MR ≤ 130
20 ≤ atoms ≤ 70

None
Veber?

Veber (GSK) filter: implemented from
Veber DF. et al. 2002 J. Med. Chem.
Rotatable bonds ≤ 10
TPSA ≤ 140

0.0
Egan?

Egan (Pharmacia) filter: implemented from
Egan WJ. et al. 2000 J. Med. Chem.
WLOGP ≤ 5.88
TPSA ≤ 131.6

0.0
Muegge?

Muegge (Bayer) filter: implemented from
Muegge I. et al. 2001 J. Med. Chem.
200 ≤ MW ≤ 600
-2 ≤ XLOGP ≤ 5
TPSA ≤ 150
Num. rings ≤ 7
Num. carbon > 4
Num. heteroatoms > 1
Num. rotatable bonds ≤ 15
H-bond acc. ≤ 10
H-bond don. ≤ 5

0.0
Bioavailability Score?

Abbott Bioavailability Score: Probability of F > 10% in rat
implemented from
Martin YC. 2005 J. Med. Chem.

0.55

Medicinal Chemistry

PAINS?

Pan Assay Interference Structures: implemented from
Baell JB. & Holloway GA. 2010 J. Med. Chem.

0.0 alert
Brenk?

Structural Alert: implemented from
Brenk R. et al. 2008 ChemMedChem

1.0 alert: heavy_metal
Leadlikeness?

Leadlikeness: implemented from
Teague SJ. 1999 Angew. Chem. Int. Ed.
250 ≤ MW ≤ 350
XLOGP ≤ 3.5
Num. rotatable bonds ≤ 7

No; 1 violation:MW<1.0
Synthetic accessibility?

Synthetic accessibility score: from 1 (very easy) to 10 (very difficult)
based on 1024 fragmental contributions (FP2) modulated by size and complexity penaties,
trained on 12'782'590 molecules and tested on 40 external molecules (r2 = 0.94)

1.4

Application In Synthesis of [ 126712-07-0 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 126712-07-0 ]

[ 126712-07-0 ] Synthesis Path-Downstream   1~34

  • 1
  • [ 79-24-3 ]
  • [ 126712-07-0 ]
  • [ 139102-36-6 ]
  • 2
  • 2-(2-methoxy-phenyl)-1-methyl-imidazolidine [ No CAS ]
  • [ 29866-54-4 ]
  • [ 126712-07-0 ]
  • 4
  • [ 126712-07-0 ]
  • 3-bromo-2-(1-hydroxy-3-methyl-but-2-enyl)-phenol [ No CAS ]
  • 5
  • [ 126712-07-0 ]
  • 5-bromo-2,2-dimethyl-4-(2-methyl-propenyl)-2<i>H</i>-chromene [ No CAS ]
  • 6
  • [ 126712-07-0 ]
  • 3-bromo-2-[3-methyl-1-(2-methyl-propenyl)-but-2-enyl]-phenol [ No CAS ]
  • 9
  • [ 126712-07-0 ]
  • [ 622829-59-8 ]
  • 10
  • [ 126712-07-0 ]
  • [ 579488-92-9 ]
  • 11
  • [ 126712-07-0 ]
  • [ 206002-16-6 ]
  • 12
  • [ 135-02-4 ]
  • α-amino-phenylacetic acid amide [ No CAS ]
  • [ 126712-07-0 ]
  • 13
  • [ 124639-28-7 ]
  • [ 126712-07-0 ]
YieldReaction ConditionsOperation in experiment
52% o-Anisaldehyde (10.0 g, 73.4 mmol, 1.0 equiv) was dissolved in EtOH (150 mL) at 25 CC, MAT-dimemylethylenediamine (8.70 mL, 80.8 mmol, 1.1 equiv) was added, and the reaction contents were stirred at 25 C for 24 h before being filtered through a pad of MgS04 and concentrated to afford the desired imidazolidine (15.0 g, 99% yield) as a white solid. Without any additional purification, this material (15.0 g, 72.8 mmol, 1.0 equiv) was dissolved in Et20 (250 mL) and cooled to -40 C. f-BuLi (1.7 M in pentane. 100 mL 170 mmol, 2.34 equiv) was then added dropwise over 1 h at -40 C. Upon completion, the resultant orange reaction contents were warmed slowly to -20 C. stirred for an additional 7 h, and then transferred by cannula over 5 min into a flask containing (CBrCl2)2 (55.3 g, 170 mmol, 2.34 equiv) in Et20 (250 mL) at 0 C. The reaction contents were then stirred for 12 h, during which time they were warmed to 25 C; upon completion, the solution was recooled to 0 C and 1 M HCI (500 mL) was added slowly. The resultant solution was stirred for 1 h at 0 C, quickly warmed to 25 C, and then quenched by the addition of water (500 mL). The reaction contents were then extracted with EtOAc (3 x 250 mL), and the combined organic extracts were washed with water (500 mL) and brine (250 mL). dried (MgSO-i), and 73 concentrated.'23' The resultant crude yellow solid was purified by flash column chromatography (silica gel, hexanes EtOAc, 9/1) to give the desired brominated product 28 (8.12 g, 52% yield) as a white solid. This material (8.12 g, 37.8 mmol, 1.0 equiv) was suspended in MeOH (100 mL) at 25 C and cooled to 0 C. NaBHj (2.88g , 75.6 mmol, 2.0 equiv) was added portionwise and the reaction contents were stirred for 1 h at 0 C. Upon completion, the reaction contents were quenched with water (100 mL) and concentrated. The reaction contents were redissolved in EtOAc ( 100 mL), poured into water (100 mL), and extracted with EtOAc (3 x 50 mL). The combined organic extracts were washed with water ( 150 mL) and brine (50 mL), dried (MgSO- , and concentrated to afford the desired alcohol (7.83 g, 96%) as a white solid. Pressing forward without any additional purification, this newly prepared material (7.83 g, 36.1 mmol, 1.0 equiv) was dissolved in EtjO (180 mL) and pyridine (0.437 mL, 5.41 mmol, 0.15 equiv) and PBr^ (3.41 mL, 36.1 mmol, 1.0 equiv) were added sequentially at 25 C. The reaction contents were then stirred for 4 h at 25 C. Upon completion, the reaction contents were quenched by the addition of water (100 mL), poured into water ( 100 ml), and extracted with EtOAc (3 x 150 mL). The combined organic extracts were washed with water (200 mL) and brine (100 mL), dried (MgS04), and concentrated to give the desired bromide (10.0 g, 99%) as a white solid. [Note: This product quickly decomposes on standing once it is neat and should be carried forward immediately. | Finally, KHMDS (0.5 M in toluene, 129 mL, 64.5 mmol, 1.8 equiv) was added to a solution of diethyl phosphite (9.19 mL, 71.4 mmol, 2.0 equiv) in THF (100 mL) at 0 C and stirred for 15 min. To this solution was added dropwise a solution of the freshly prepared bromide (10.0 g, 35.7 mmol, 1.0 equiv) dissolved in THF (100 mL), and the reaction contents were stirred for 12 h with slow warming to 25 C. Upon completion, the reaction contents were quenched with saturated NH4CI (150 mL), poured into water (150 mL), and extracted with EtOAc (3 x 150 mL). The combined organic extracts were washed with water (100 mL) and brine (100 mL), dried (MgS04), and concentrated to give the phosphonate 31 (10.79 g, 90%) as a colorless oil. 31: R/ = 0.21 (silica gel, EtOAc); IR (film) vmax 2981, 1589, 1572, 1466, 1435, 1267, 1082, 965, 864, 771 ; NMR (400 MHz, CDCI3) delta 7.18 (d, / = 8.0 Hz, 1 H), 7.07 (app dt, J = 8.0, 2.4 Hz, 1 H), 6.81 (d, J = 8.4 Hz, 1 H), 4.05 (dq, J = 7.2, 7.2 Hz, 4 H), 3.85 (s, 3 H), 3.50 (d, J = 22.0 Hz, 2 H), 1.26 (t, J = 7.2 Hz, 6 H); l3C NMR (75 MHz, CDCI3) delta 158.4 (d, J = 5.4 Hz). 128.6 (d, J = 3.8 Hz), 125.8 (d, J = 7.5 Hz), 125.0 (d, J = 3.5 Hz), 121.6 (d, J = 10.6 Hz), 109.4 (d, J = 3.4 Hz), 61.9 (d, J = 6.5 Hz), 55.9, 28.3 (d, J = 139.0 Hz), 16.3 (d, J = 6.4 Hz); HRMS (MALDI-FTMS) calcd for Ci2H|9BrP04+ [M + H*] 337.0204, found 337.0189. 74
  • 14
  • [ 591-20-8 ]
  • [ 126712-07-0 ]
  • 15
  • [ 126712-07-0 ]
  • [ 139102-28-6 ]
  • 16
  • [ 126712-07-0 ]
  • [ 93710-52-2 ]
YieldReaction ConditionsOperation in experiment
96% o-Anisaldehyde (10.0 g, 73.4 mmol, 1.0 equiv) was dissolved in EtOH (150 mL) at 25 CC, MAT-dimemylethylenediamine (8.70 mL, 80.8 mmol, 1.1 equiv) was added, and the reaction contents were stirred at 25 C for 24 h before being filtered through a pad of MgS04 and concentrated to afford the desired imidazolidine (15.0 g, 99% yield) as a white solid. Without any additional purification, this material (15.0 g, 72.8 mmol, 1.0 equiv) was dissolved in Et20 (250 mL) and cooled to -40 C. f-BuLi (1.7 M in pentane. 100 mL 170 mmol, 2.34 equiv) was then added dropwise over 1 h at -40 C. Upon completion, the resultant orange reaction contents were warmed slowly to -20 C. stirred for an additional 7 h, and then transferred by cannula over 5 min into a flask containing (CBrCl2)2 (55.3 g, 170 mmol, 2.34 equiv) in Et20 (250 mL) at 0 C. The reaction contents were then stirred for 12 h, during which time they were warmed to 25 C; upon completion, the solution was recooled to 0 C and 1 M HCI (500 mL) was added slowly. The resultant solution was stirred for 1 h at 0 C, quickly warmed to 25 C, and then quenched by the addition of water (500 mL). The reaction contents were then extracted with EtOAc (3 x 250 mL), and the combined organic extracts were washed with water (500 mL) and brine (250 mL). dried (MgSO-i), and 73 concentrated.'23' The resultant crude yellow solid was purified by flash column chromatography (silica gel, hexanes EtOAc, 9/1) to give the desired brominated product 28 (8.12 g, 52% yield) as a white solid. This material (8.12 g, 37.8 mmol, 1.0 equiv) was suspended in MeOH (100 mL) at 25 C and cooled to 0 C. NaBHj (2.88g , 75.6 mmol, 2.0 equiv) was added portionwise and the reaction contents were stirred for 1 h at 0 C. Upon completion, the reaction contents were quenched with water (100 mL) and concentrated. The reaction contents were redissolved in EtOAc ( 100 mL), poured into water (100 mL), and extracted with EtOAc (3 x 50 mL). The combined organic extracts were washed with water ( 150 mL) and brine (50 mL), dried (MgSO- , and concentrated to afford the desired alcohol (7.83 g, 96%) as a white solid. Pressing forward without any additional purification, this newly prepared material (7.83 g, 36.1 mmol, 1.0 equiv) was dissolved in EtjO (180 mL) and pyridine (0.437 mL, 5.41 mmol, 0.15 equiv) and PBr^ (3.41 mL, 36.1 mmol, 1.0 equiv) were added sequentially at 25 C. The reaction contents were then stirred for 4 h at 25 C. Upon completion, the reaction contents were quenched by the addition of water (100 mL), poured into water ( 100 ml), and extracted with EtOAc (3 x 150 mL). The combined organic extracts were washed with water (200 mL) and brine (100 mL), dried (MgS04), and concentrated to give the desired bromide (10.0 g, 99%) as a white solid. [Note: This product quickly decomposes on standing once it is neat and should be carried forward immediately. | Finally, KHMDS (0.5 M in toluene, 129 mL, 64.5 mmol, 1.8 equiv) was added to a solution of diethyl phosphite (9.19 mL, 71.4 mmol, 2.0 equiv) in THF (100 mL) at 0 C and stirred for 15 min. To this solution was added dropwise a solution of the freshly prepared bromide (10.0 g, 35.7 mmol, 1.0 equiv) dissolved in THF (100 mL), and the reaction contents were stirred for 12 h with slow warming to 25 C. Upon completion, the reaction contents were quenched with saturated NH4CI (150 mL), poured into water (150 mL), and extracted with EtOAc (3 x 150 mL). The combined organic extracts were washed with water (100 mL) and brine (100 mL), dried (MgS04), and concentrated to give the phosphonate 31 (10.79 g, 90%) as a colorless oil. 31: R/ = 0.21 (silica gel, EtOAc); IR (film) vmax 2981, 1589, 1572, 1466, 1435, 1267, 1082, 965, 864, 771 ; NMR (400 MHz, CDCI3) delta 7.18 (d, / = 8.0 Hz, 1 H), 7.07 (app dt, J = 8.0, 2.4 Hz, 1 H), 6.81 (d, J = 8.4 Hz, 1 H), 4.05 (dq, J = 7.2, 7.2 Hz, 4 H), 3.85 (s, 3 H), 3.50 (d, J = 22.0 Hz, 2 H), 1.26 (t, J = 7.2 Hz, 6 H); l3C NMR (75 MHz, CDCI3) delta 158.4 (d, J = 5.4 Hz). 128.6 (d, J = 3.8 Hz), 125.8 (d, J = 7.5 Hz), 125.0 (d, J = 3.5 Hz), 121.6 (d, J = 10.6 Hz), 109.4 (d, J = 3.4 Hz), 61.9 (d, J = 6.5 Hz), 55.9, 28.3 (d, J = 139.0 Hz), 16.3 (d, J = 6.4 Hz); HRMS (MALDI-FTMS) calcd for Ci2H|9BrP04+ [M + H*] 337.0204, found 337.0189. 74
  • 17
  • [ 68204-79-5 ]
  • [ 126712-07-0 ]
  • (E)-3-(2-bromo-6-methoxyphenyl)-2-(2-methoxycarbonyl-4,5-methylenedioxyphenyl)acrylic acid methyl ester [ No CAS ]
  • (Z)-3-(2-bromo-6-methoxyphenyl)-2-(2-methoxycarbonyl-4,5-methylenedioxyphenyl)acrylic acid methyl ester [ No CAS ]
  • 18
  • [ 68204-79-5 ]
  • [ 126712-07-0 ]
  • [ 1294495-52-5 ]
  • 19
  • 2-bromo-6-methoxybenzaldehyde O-methyloxime [ No CAS ]
  • [ 126712-07-0 ]
  • 20
  • [ 107369-63-1 ]
  • [ 126712-07-0 ]
  • 21
  • [ 126712-07-0 ]
  • [ 126712-05-8 ]
  • 22
  • [ 126712-07-0 ]
  • [ 1242319-64-7 ]
  • 23
  • [ 126712-07-0 ]
  • [ 1242319-88-5 ]
  • 24
  • [ 126712-07-0 ]
  • C41H38O7 [ No CAS ]
  • 25
  • [ 126712-07-0 ]
  • [ 1331748-27-6 ]
  • 26
  • [ 126712-07-0 ]
  • [ 1242319-89-6 ]
  • 27
  • [ 126712-07-0 ]
  • C34H32O6 [ No CAS ]
  • 28
  • [ 126712-07-0 ]
  • C32H28O5 [ No CAS ]
  • 29
  • [ 126712-07-0 ]
  • C32H26O5 [ No CAS ]
  • 30
  • [ 126712-07-0 ]
  • C32H24O6 [ No CAS ]
  • 31
  • [ 126712-07-0 ]
  • [ 1065011-04-2 ]
  • 32
  • [ 126712-07-0 ]
  • C29H20O5 [ No CAS ]
  • 33
  • [ 126712-07-0 ]
  • C32H26O6 [ No CAS ]
  • 34
  • [ 126712-07-0 ]
  • [ 1384847-56-6 ]
 

Historical Records

Technical Information

• Alkyl Halide Occurrence • Barbier Coupling Reaction • Baylis-Hillman Reaction • Benzylic Oxidation • Birch Reduction • Blanc Chloromethylation • Bucherer-Bergs Reaction • Clemmensen Reduction • Complex Metal Hydride Reductions • Corey-Chaykovsky Reaction • Corey-Fuchs Reaction • Fischer Indole Synthesis • Friedel-Crafts Reaction • General Reactivity • Grignard Reaction • Hantzsch Dihydropyridine Synthesis • Henry Nitroaldol Reaction • Hiyama Cross-Coupling Reaction • Horner-Wadsworth-Emmons Reaction • Hydride Reductions • Hydrogenolysis of Benzyl Ether • Julia-Kocienski Olefination • Kinetics of Alkyl Halides • Knoevenagel Condensation • Kumada Cross-Coupling Reaction • Leuckart-Wallach Reaction • McMurry Coupling • Meerwein-Ponndorf-Verley Reduction • Mukaiyama Aldol Reaction • Nomenclature of Ethers • Nozaki-Hiyama-Kishi Reaction • Passerini Reaction • Paternò-Büchi Reaction • Petasis Reaction • Pictet-Spengler Tetrahydroisoquinoline Synthesis • Preparation of Aldehydes and Ketones • Preparation of Alkylbenzene • Preparation of Amines • Preparation of Ethers • Prins Reaction • Reactions of Aldehydes and Ketones • Reactions of Alkyl Halides with Reducing Metals • Reactions of Amines • Reactions of Benzene and Substituted Benzenes • Reactions of Dihalides • Reactions of Ethers • Reformatsky Reaction • Schlosser Modification of the Wittig Reaction • Schmidt Reaction • Stetter Reaction • Stille Coupling • Stobbe Condensation • Substitution and Elimination Reactions of Alkyl Halides • Suzuki Coupling • Tebbe Olefination • Ugi Reaction • Vilsmeier-Haack Reaction • Wittig Reaction • Wolff-Kishner Reduction

Categories

Related Functional Groups of
[ 126712-07-0 ]

Aryls

Chemical Structure| 7507-86-0

A218152 [7507-86-0]

2-Bromo-5-methoxybenzaldehyde

Similarity: 0.94

Chemical Structure| 43192-32-1

A415887 [43192-32-1]

2-Bromo-5-ethoxybenzaldehyde

Similarity: 0.91

Chemical Structure| 380225-68-3

A133523 [380225-68-3]

1-(2-Bromo-6-methoxyphenyl)ethanone

Similarity: 0.90

Chemical Structure| 60632-40-8

A162285 [60632-40-8]

2-Bromo-4-hydroxy-5-methoxybenzaldehyde

Similarity: 0.89

Chemical Structure| 85604-06-4

A125341 [85604-06-4]

5-(Benzyloxy)-2-bromobenzaldehyde

Similarity: 0.88

Bromides

Chemical Structure| 7507-86-0

A218152 [7507-86-0]

2-Bromo-5-methoxybenzaldehyde

Similarity: 0.94

Chemical Structure| 43192-32-1

A415887 [43192-32-1]

2-Bromo-5-ethoxybenzaldehyde

Similarity: 0.91

Chemical Structure| 380225-68-3

A133523 [380225-68-3]

1-(2-Bromo-6-methoxyphenyl)ethanone

Similarity: 0.90

Chemical Structure| 60632-40-8

A162285 [60632-40-8]

2-Bromo-4-hydroxy-5-methoxybenzaldehyde

Similarity: 0.89

Chemical Structure| 85604-06-4

A125341 [85604-06-4]

5-(Benzyloxy)-2-bromobenzaldehyde

Similarity: 0.88

Aldehydes

Chemical Structure| 7507-86-0

A218152 [7507-86-0]

2-Bromo-5-methoxybenzaldehyde

Similarity: 0.94

Chemical Structure| 43192-32-1

A415887 [43192-32-1]

2-Bromo-5-ethoxybenzaldehyde

Similarity: 0.91

Chemical Structure| 60632-40-8

A162285 [60632-40-8]

2-Bromo-4-hydroxy-5-methoxybenzaldehyde

Similarity: 0.89

Chemical Structure| 85604-06-4

A125341 [85604-06-4]

5-(Benzyloxy)-2-bromobenzaldehyde

Similarity: 0.88

Chemical Structure| 162147-12-8

A173282 [162147-12-8]

2-Bromo-5-isopropoxybenzaldehyde

Similarity: 0.88

Ethers

Chemical Structure| 7507-86-0

A218152 [7507-86-0]

2-Bromo-5-methoxybenzaldehyde

Similarity: 0.94

Chemical Structure| 43192-32-1

A415887 [43192-32-1]

2-Bromo-5-ethoxybenzaldehyde

Similarity: 0.91

Chemical Structure| 380225-68-3

A133523 [380225-68-3]

1-(2-Bromo-6-methoxyphenyl)ethanone

Similarity: 0.90

Chemical Structure| 60632-40-8

A162285 [60632-40-8]

2-Bromo-4-hydroxy-5-methoxybenzaldehyde

Similarity: 0.89

Chemical Structure| 85604-06-4

A125341 [85604-06-4]

5-(Benzyloxy)-2-bromobenzaldehyde

Similarity: 0.88